3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
4
Ovarian Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Leiomyosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Endometrioid
1
Interventions
Cyclophosphamide
9
glofitamab
4
Whole-Body Irradiation
4
Rituximab
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
cediranib
×
1 year
×
Clear all
No trials found.